Wakamiya T, Iwagami S, Enyo N, Shibano S, et al. Structured Symptom Monitoring During Enfortumab Vedotin Plus Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma: Multicenter Retrospective Study. Anticancer Res 2026;46:5639-5650.
PMID: 42823162